Table 1 The baseline characteristics of the patients in both groups

Male: female

20:14

17:14

0.805

Age (years)

51.9 ± 9.8

51.0 ± 8.9

0.784

Duration of DM (months)

126.9 ± 68.1

106.8 ± 57.3

0.270

Duration of DN (months)

33.8 ± 30.6

26.1 ± 28.4

0.277

ACEI or ARB treatment before the screening phase (n,%)

17, 50%

10, 32.3%

0.208

Systolic blood pressure (mmHg)

140.6 ± 15.8

138.3 ± 17.1

0.515

Diastolic blood pressure (mmHg)

81.6 ± 11.9

84.4 ± 11.1

0.233

FBG (mmol/L)

6.04 ± 1.51

6.70 ± 1.62

0.092

Glycosylated hemoglobin (%)

6.26 ± 1.15

6.68 ± 1.26

0.202

Serum albumin (g/L)

33.0 ± 5.66

33.07 ± 4.74

0.988

Total cholesterol (mmol/L)

6.08 ± 1.96

5.92 ± 2.21

0.702

Triglycerides (mmol/L)

1.85 ± 0.83

2.50 ± 2.10

0.111

Serum creatinine (mg/dl)

1.92 ± 0.72

1.67 ± 0.62

0.117

eGFR (ml/min/1.73 m²)

43.07 ± 21.65

47.72 ± 20.34

0.377

Serum creatinine > 1.5 mg/dl (%)

70.6%

54.8%

0.210

Urine protein (g/24 h)

4.99 ± 2.25

4.15 ± 1.29

0.097